Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 13, 2021

SELL
$142.45 - $169.82 $198,005 - $236,049
-1,390 Closed
0 $0
Q2 2021

Aug 02, 2021

BUY
$135.08 - $161.1 $187,761 - $223,929
1,390 New
1,390 $219,000
Q1 2021

Apr 20, 2021

SELL
$137.51 - $190.8 $175,737 - $243,842
-1,278 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$164.63 - $211.93 $210,397 - $270,846
1,278 New
1,278 $224,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Alta Wealth Advisors LLC Portfolio

Follow Alta Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alta Wealth Advisors LLC with notifications on news.